5-Aminolevulinic acid-based photodynamic therapy suppressed survival factors and activated proteases for apoptosis in human glioblastoma U87MG cells
- 11 February 2007
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 415 (3) , 242-247
- https://doi.org/10.1016/j.neulet.2007.01.071
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cellsNeuroscience Letters, 2006
- Cross-talk between two apoptotic pathways activated by endoplasmic reticulum stress: differential contribution of caspase-12 and AIFApoptosis, 2006
- Targeting PBR by Hexaminolevulinate-Mediated Photodynamic Therapy Induces Apoptosis through Translocation of Apoptosis-Inducing Factor in Human Leukemia CellsCancer Research, 2005
- RNA expression profiling of normal and tumor cells following photodynamic therapy with 5-aminolevulinic acid–induced protoporphyrin IX in vitroMolecular Cancer Therapeutics, 2005
- Dexamethasone decreases temozolomide‐induced apoptosis in human gliobastoma T98G cellsGlia, 2005
- Inhibition of IAP's protection by Diablo/Smac: new therapeutic opportunities?Cell Death & Differentiation, 2000
- Simultaneous Degradation of αII- and βII-Spectrin by Caspase 3 (CPP32) in Apoptotic CellsJournal of Biological Chemistry, 1998
- HOW DOES PHOTODYNAMIC THERAPY WORK?Photochemistry and Photobiology, 1992
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970